TELA Bio (TELA) Interest Coverage Ratio Growth (1y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -40.19% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 3.52% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -12.04% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 8.92% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -54.61% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -6.18% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 66.99% |
| 10 | TELA Bio | 13.26 Mn | -26.28 Mn | 12.52 Mn | 40.32% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 40.32% |
| Dec 31, 2025 | -129.30% |
| Sep 30, 2025 | 9.73% |
| Jun 30, 2025 | 12.06% |
| Mar 31, 2025 | -137.11% |
| Dec 31, 2024 | 251.84% |
| Sep 30, 2024 | 8.70% |
| Jun 30, 2024 | -8.89% |
| Mar 31, 2024 | 59.89% |
| Dec 31, 2023 | -13.54% |
| Sep 30, 2023 | 16.98% |
| Jun 30, 2023 | 27.16% |
| Mar 31, 2023 | 16.41% |
| Dec 31, 2022 | 3.15% |
| Sep 30, 2022 | -17.44% |
| Jun 30, 2022 | -29.53% |
| Mar 31, 2022 | -32.15% |
| Dec 31, 2021 | -11.11% |
| Sep 30, 2021 | -2.42% |
| Jun 30, 2021 | -44.80% |
| Mar 31, 2021 | -10.59% |
| Dec 31, 2020 | -13.37% |
| Sep 30, 2020 | -78.18% |
| Jun 30, 2020 | -24.22% |
| Mar 31, 2020 | -30.17% |
| Dec 31, 2019 | 8.30% |
| Sep 30, 2019 | 47.49% |